Pharmaceutical compositions using thiazepine
DC CAFCFirst Claim
Patent Images
1. A sustained release formulation comprising a gelling agent and 11 - 4- 2-(2-hydroxyethoxy)ethyl!- 1 -piperazinyl!dibenzo- b,f! 1,4!thiazepine or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable excipients.
3 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The invention relates to sustained release formulations comprising 11- 4- 2-(2-hydroxyethoxy)ethyl!-1-piperazinyl!dibenzo b,f! 1,4!thiazepine or a pharmaceutically acceptable salt thereof, to methods of treating psychotic states and hyperactivity utilizing the sustained release formulations and to a process for preparing the sustained release formulations.
73 Citations
15 Claims
- 1. A sustained release formulation comprising a gelling agent and 11 - 4- 2-(2-hydroxyethoxy)ethyl!- 1 -piperazinyl!dibenzo- b,f! 1,4!thiazepine or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable excipients.
Specification